Artificial Pancreas Device Systems Market By Device Type(Threshold Suspend Device Systems, Control-to-Range (CTR) Systems, Control-to-Target (CTT) Systems) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Key Highlights of the report

How are the major segments performing in the artificial pancreas device systems market?

• In 2022, the control-to-target (CTT) systems segment accounted for the largest share of the market. The CTT system is a fully automated technology requiring little patient involvement, which will influence the market’s growth pace.

What is the market size of artificial pancreas device systems regarding value?

The global artificial pancreas device systems market is anticipated to grow at a substantial CAGR of 19.50% in the upcoming years. The global artificial pancreas device systems industry was estimated to be worth USD 0.3 billion in 2022 and was expected to be worth USD 1.04 billion by 2030.

Which region dominated the artificial pancreas device systems market?

In 2022, the North American region was anticipated to hold a prominent share of the global artificial pancreas device systems market. The region is anticipated to be driven by rising rates of obesity, effective reimbursement systems, and increased knowledge of cutting-edge solutions for managing diabetes. The existence of significant players, high treatment costs, technical advancements, and product releases are additional factors anticipated to boost the regional market. Additionally, the growing number of diabetics worldwide has prompted both public and commercial organizations to invest in research into diabetes management.

Which are the key countries in the artificial pancreas device systems market?

In 2022, the United States was anticipated to be a leading nation in terms of market growth due to a variety of causes, including the rising incidence of diabetes, the country’s strong industry presence, improved healthcare infrastructure, increased knowledge of existing technologies among the general public and stakeholders in the healthcare industry, and the concentration of market players. In the United States of America, 32.2 million people (20-79 years old) have diabetes in 2021, and it’s predicted that 36.3 million people will have it by 2045.

India was predicted to command a significant portion of the global artificial pancreas device systems market in 2022. This is primarily caused by an increase in the number of people with diabetes, a rise in the demand for artificial pancreas device systems in this country, the presence of well-established businesses, the quick uptake of cutting-edge technologies, high healthcare spending, and extensive research and development by major corporations, all of which contribute to the market’s growth.

How is the economy impacting the global artificial pancreas device systems growth?

The ongoing COVID-19 pandemic has only slightly decreased the need for artificial pancreas device systems. There is a need for quarantine units to stop the virus’ transmission while governments and medical professionals are working on diagnosing and treating COVID-19-affected people worldwide. As a result of the lockout, persons with chronic diseases like diabetes are experiencing stress due to their medications and diagnostic equipment.

What is the competitive environment of the artificial pancreas device systems market?

Major market players use tactics including partnerships, mergers and acquisitions, and the introduction of innovative, high-tech goods and services to increase their market share. To produce highly improved items, they are heavily spending on R&D. For instance, Medtronic’s MiniMed 780G was awarded CE-Mark in June 2020. For diabetic patients aged 7 to 80, the gadget automatically modifies basal insulin rates every five minutes. Similarly, the U.S. FDA approved a next-generation hybrid closed-loop insulin delivery system for children with type 1 diabetes between the ages of 2 and 6 in September 2020.

Executive Summary

What are the key trends in the artificial pancreas device systems market?

• The increased prevalence of diabetes worldwide is one of the main factors propelling growth in the artificial pancreas industry. Diabetes is a chronic condition that develops when the pancreas does not create enough insulin or when the body is unable to use insulin properly. If untreated, hyperglycemia, or high blood sugar, can cause serious harm or complications that could endanger the person’s life. The disease’s burden is rapidly increasing on a global scale. The prevalence of both type 1 and type 2 diabetes is rising, which will increase healthcare expenses globally. Obesity, smoking, a sedentary lifestyle, and expanding urbanization are the factors causing an increase in diabetics.

How has the rise in diabetes awareness campaigns influenced the market?

In order to raise awareness of diabetes and gather data for product improvement, vendors are holding summits. For instance, the European Foundation for the Study of Diabetes (EFSD) is a major European organization that funds research into diabetes to raise and promote public awareness of type 1 diabetes. The Juvenile Diabetes Research Foundation (JDRF) supports research, promotes laws that increase patient access to medications, and offers a centralized support system for people with type 1 diabetes to combat the disease. Throughout the projected period, the market will expand at a faster rate thanks to various activities implemented to raise diabetes management awareness in the area. These programs educate participants on numerous methods and daily activities for preventing, managing, and controlling diabetes. As a result, diabetic patients would have an increased need for an artificial pancreas, propelling the market’s expansion.

Which are the key investments by the artificial pancreas device systems market players?

Significant investments are being made in the APDS business, spurring more research and development. This leads to the creation of new, cutting-edge APDS products, which are predicted to expand the market. Additionally, the growing number of diabetics around the world has attracted research funding for diabetes care from both corporate and public organizations. For instance, 2019, the National Institutes of Health (NIH) invested in close-loop insulin administration technology for type 1 diabetic pregnant women in partnership with four other universities.

Some major players in the artificial pancreas device systems market are GE Healthcare; Philips; SunTech Medical, Inc.; Omron Healthcare, Inc.; Spacelabs Healthcare Inc.; American Diagnostic Corporation; Hill-Rom Services; Midmark; Cardinal Health; and Medline Industries.

What are the major driving factors for the artificial pancreas device systems market?

One of the main factors propelling the market’s expansion is the rising incidence of chronic diseases like pancreatitis, pancreatic cancer, and other similar conditions. A further driver in the global acceptance of APDS is the rising incidence of diabetes and obesity, which is brought on by age-related factors, physical inactivity, and bad eating habits. The market is expanding due to the increased need for effective diabetes monitoring and minimally invasive (MI) drug delivery devices. The development of software-based wireless systems linked with automated controls is only one example of the numerous technological advancements fuelling the market’s expansion.

What are the major risks for the artificial pancreas device systems market?

The equipment’s high installation costs will be a significant market growth inhibitor. Unfavorable reimbursement practices, particularly in developing economies, will make it harder for the market to expand. However, the absence of qualified specialists in developing areas like Africa and South America is anticipated to impede market expansion.

Which is the key device type in the artificial pancreas device systems market?

The control-to-target (CTT) systems segment is expected to hold a prominent share of the global market during the forecast period. The CTT systems completely automate insulin administration, monitor blood glucose levels, and do not require patient involvement. As a result, a stronger impetus for the CTT system is anticipated during the forecast period. In addition, the International Diabetes Federation (IDF) estimates that in 2021 there will be 537 million adults worldwide who will have diabetes. In 2030 and 2045, this number is expected to increase to 643 million and 783 million. Diabetes-related causes were to blame for about 6.7 million deaths in 2021. Therefore, due to the huge base of diabetics and rising diabetes incidence, the demand for CTT systems is expected to increase during the forecast period.

How is the artificial pancreas device systems market performing in regions?

Asia Pacific market is anticipated to witness fastest growth in the global artificial pancreas device systems market during the forecast period. Major reasons promoting growth in this area include increased healthcare funding and government campaigns to raise awareness of diabetes. The International Diabetes Federation reports that China and India have the most diabetic patients worldwide. Type I and type II diabetes have become more common in most of the emerging nations in this region due to rising obesity rates and rapid socioeconomic development. Diabetes is becoming more common, but medical expenses were far lower. Additionally, it is projected that the industry will grow as a result of developing economies adopting new technology.

What is the regulatory landscape for the artificial pancreas device systems market?

Governments and regulatory agencies from different countries are making major investments in research and development (R&D) to advance the global healthcare system. For instance, the Food and Drug Association (US FDA) in the United States is authorizing a growing number of novel and ground-breaking items, fostering optimism for the domestic market.

What are the major players planning for the future of the artificial pancreas device systems market?

Increasing technology integration will drive the artificial pancreas market in the coming years. Growing technological integration in the industry is anticipated to accelerate market expansion. Due to the rising demand for an Artificial Pancreas Device System (APDS) that can mimic the function of a healthy pancreas, the producers have focused solely on cutting-edge technology. The integration of sensors, software, and associated algorithms is necessary for the correct operation of APDS. For example, SmartGuard Technology is incorporated into the MiniMed 530G system from Medtronic, which helps to provide adequate glucose management.

REPORT ATTRIBUTE	DETAILS
Artificial Pancreas Device Systems Market by Volume	No
Artificial Pancreas Device Systems Market by Value	Yes
Artificial Pancreas Device Systems Market, Tornado Analysis	Yes
Artificial Pancreas Device Systems Market, STAR Analysis	Yes
Artificial Pancreas Device Systems Market, SRC Analysis	Yes
Artificial Pancreas Device Systems Market, Import-Export Data	Yes (On Demand)
Artificial Pancreas Device Systems Market Pricing Analysis	Yes (On Demand)
Artificial Pancreas Device Systems Market Segment Analysis	By Device Type (Threshold Suspend Device Systems, Control-to-Range (CTR) Systems and Control-to-Target (CTT) Systems)
Artificial Pancreas Device Systems Market, Regional Analysis	North America (US, Canada, Mexico) Europe (Germany, UK, France, Italy, Spain, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Argentina, and Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)
Artificial Pancreas Device Systems Market Key Companies	GE Healthcare; Philips; SunTech Medical, Inc.; Omron Healthcare, Inc.; Spacelabs Healthcare Inc.; American Diagnostic Corporation; Hill-Rom Services; Midmark; Cardinal Health; Medline Industries
Artificial Pancreas Device Systems Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global Artificial Pancreas Device Systems Market-

Global Artificial Pancreas Device Systems Market – By Device Type

• Threshold Suspend Device Systems
• Control-to-Range (CTR) Systems
• Control-to-Target (CTT) Systems

Global Artificial Pancreas Device Systems Market – By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue-Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Artificial Pancreas Device Systems Market
2.2. Global Artificial Pancreas Device Systems Market, By Device Type
2.3. Global Artificial Pancreas Device Systems Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Artificial Pancreas Device Systems Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Device Type
3.5.2. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company Market Share of Key Players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Artificial Pancreas Device Systems Market, By Device Type
7.1. Global Artificial Pancreas Device Systems Market Overview, by Device Type
7.1.1. Global Artificial Pancreas Device Systems Market Revenue Share, By Device Type, 2022 Vs 2030 (in %)
7.2. Threshold Suspend Device Systems
7.2.1. Global Artificial Pancreas Device Systems Market, By Region, 2017-2030 (US$ Bn)
7.3. Control-to-Range (CTR) Systems
7.3.1. Global Artificial Pancreas Device Systems Market, By Region, 2017-2030 (US$ Bn)
7.4. Control-to-Target (CTT) Systems
7.4.1. Global Artificial Pancreas Device Systems Market, By Region, 2017-2030 (US$ Bn)

8. Global Artificial Pancreas Device Systems Market, By Region
8.1. Global Artificial Pancreas Device Systems Market Overview, by Region
8.1.1. Global Artificial Pancreas Device Systems Market, By Region, 2022 vs 2030 (in%)
8.2. Device Type
8.2.1. Global Artificial Pancreas Device Systems Market, By Device Type, 2017-2030 (US$ Bn)

9. North America Artificial Pancreas Device Systems Market Analysis
9.1. North America Artificial Pancreas Device Systems Market, by Device Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. North America Artificial Pancreas Device Systems Market, by Country, 2017-2030 (US$ Bn)
9.2.1. North America Artificial Pancreas Device Systems Market, by Country, 2022 Vs 2030 (in%)
9.2.2. U.S.
9.2.2.1. U.S. Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.2.2. U.S. Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
9.2.3. Canada
9.2.3.1. Canada Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.3.2. Canada Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
9.2.4. Mexico
9.2.4.1. Mexico Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.4.2. Mexico Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)

10. Europe Artificial Pancreas Device Systems Market Analysis
10.1. Europe Artificial Pancreas Device Systems Market, by Device Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Europe Artificial Pancreas Device Systems Market, by Country, 2017-2030 (US$ Bn)
10.2.1. Europe Artificial Pancreas Device Systems Market, by Country, 2022 Vs 2030 (in%)
10.2.2. Germany
10.2.2.1. Germany Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.2.2. Germany Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
10.2.3. France
10.2.3.1. France Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.3.2. France Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
10.2.4. UK
10.2.4.1. UK Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.4.2. UK Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
10.2.5. Italy
10.2.5.1. Italy Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.5.2. Italy Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
10.2.6. Spain
10.2.6.1. Spain Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.6.2. Spain Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
10.2.7. Rest of Europe
10.2.7.1. Rest of Europe Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.7.2. Rest of Europe Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)

11. Asia Pacific Artificial Pancreas Device Systems Market Analysis
11.1. Asia Pacific Artificial Pancreas Device Systems Market, by Device Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Asia Pacific Artificial Pancreas Device Systems Market, by Country, 2017-2030 (US$ Bn)
11.2.1. Asia Pacific Artificial Pancreas Device Systems Market, by Country, 2022 Vs 2030 (in%)
11.2.2. China
11.2.2.1. China Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.2.2. China Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
11.2.3. Japan
11.2.3.1. Japan Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.3.2. Japan Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
11.2.4. India
11.2.4.1. India Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.4.2. India Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
11.2.5. South Korea
11.2.5.1. South Korea Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.5.2. South Korea Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
11.2.6. South-East Asia
11.2.6.1. South-East Asia Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.6.2. South-East Asia Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
11.2.7. Rest of Asia Pacific
11.2.7.1. Rest of Asia Pacific Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.7.2. Rest of Asia Pacific Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)

12. Latin America Artificial Pancreas Device Systems Market Analysis
12.1. Latin America Artificial Pancreas Device Systems Market, by Device Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Latin America Artificial Pancreas Device Systems Market, by Country, 2017-2030 (US$ Bn)
12.2.1. Latin America Artificial Pancreas Device Systems Market, by Country, 2022 Vs 2030 (in%)
12.2.2. Brazil
12.2.2.1. Brazil Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.2.2. Brazil Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
12.2.3. Argentina
12.2.3.1. Argentina Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.3.2. Argentina Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
12.2.4. Rest of Latin America
12.2.4.1. Rest of Latin America Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.4.2. Rest of Latin America Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)

13. Middle East and Africa Artificial Pancreas Device Systems Market Analysis
13.1. Middle East and Africa Artificial Pancreas Device Systems Market, by Device Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Middle East and Africa Artificial Pancreas Device Systems Market, by Country, 2017-2030 (US$ Bn)
13.2.1. Middle East and Africa Artificial Pancreas Device Systems Market, by Country, 2022 Vs 2030 (in%)
13.2.2. GCC Countries
13.2.2.1. GCC Countries Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.2.2. GCC Countries Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
13.2.3. South Africa
13.2.3.1. South Africa Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.3.2. South Africa Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)
13.2.4. Rest of Middle East and Africa
13.2.4.1. Rest of Middle East and Africa Artificial Pancreas Device Systems Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.4.2. Rest of Middle East and Africa Artificial Pancreas Device Systems, By Device Type, 2017-2030 (US$ Bn)

14. Company Profiles
14.1. GE Healthcare
14.1.1. Company Overview
14.1.2. Products/Services Portfolio
14.1.3. Geographical Presence
14.1.4. Financial Summary
14.1.4.1. Market Revenue and Net Profit (2019-2022)
14.1.4.2. Business Segment Revenue Analysis
14.1.4.3. Geographical Revenue Analysis
14.2. Philips
14.3. SunTech Medical, Inc.
14.4. Omron Healthcare, Inc.
14.5. Spacelabs Healthcare Inc.
14.6. American Diagnostic Corporation
14.7. Hill-Rom Services
14.8. Midmark; Cardinal Health
14.9. Medline Industries

List of Figures
FIG. 1 Global Artificial Pancreas Device Systems Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Artificial Pancreas Device Systems Market Segmentation
FIG. 4 Global Artificial Pancreas Device Systems Market, by Device Type, 2022 (US$ Bn)
FIG. 5 Global Artificial Pancreas Device Systems Market, by Geography, 2022 (US$ Bn)
FIG. 6 Attractive Investment Proposition, by Device Type, 2022
FIG. 7 Attractive Investment Proposition, by Geography, 2022
FIG. 8 Global Market Share Analysis of Key Artificial Pancreas Device Systems Market Manufacturers, 2022
FIG. 9 Global Market Positioning of Key Artificial Pancreas Device Systems Market Manufacturers, 2022
FIG. 10 Global Artificial Pancreas Device Systems Market Value Contribution, By Device Type, 2022 & 2030 (Value %)
FIG. 11 Global Artificial Pancreas Device Systems Market, by Threshold Suspend Device Systems, Value, 2017-2030 (US$ Bn)
FIG. 12 Global Artificial Pancreas Device Systems Market, by Control-to-Range (CTR) Systems, Value, 2017-2030 (US$ Bn)
FIG. 13 Global Artificial Pancreas Device Systems Market, by Control-to-Target (CTT) Systems, Value, 2017-2030 (US$ Bn)
FIG. 14 North America Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 15 U.S. Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 16 Canada Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 17 Europe Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 18 Germany Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 19 France Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 20 U.K. Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 21 Italy Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 22 Spain Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 23 Rest of Europe Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 24 Asia Pacific Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 25 China Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 26 Japan Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 27 India Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 28 South Korea Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 29 South-East Asia Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 30 Rest of Asia Pacific Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 31 Latin America Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 32 Brazil Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 33 Mexico Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 34 Rest of Latin America Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 35 Middle East & Africa Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 36 GCC Countries Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 37 South Africa Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Middle East and Africa Artificial Pancreas Device Systems Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Artificial Pancreas Device Systems Market
TABLE 2 Global Artificial Pancreas Device Systems Market: Market Drivers Impact Analysis
TABLE 3 Global Artificial Pancreas Device Systems Market: Market Restraints Impact Analysis
TABLE 4 Global Artificial Pancreas Device Systems Market, by Competitive Benchmarking, 2022
TABLE 5 Global Artificial Pancreas Device Systems Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Artificial Pancreas Device Systems Market, by Key Strategies Analysis, 2022
TABLE 7 Global Artificial Pancreas Device Systems Market, by Threshold Suspend Device Systems, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Artificial Pancreas Device Systems Market, by Threshold Suspend Device Systems, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Artificial Pancreas Device Systems Market, by Control-to-Range (CTR) Systems, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Artificial Pancreas Device Systems Market, by Control-to-Range (CTR) Systems, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Artificial Pancreas Device Systems Market, by Control-to-Target (CTT) Systems, By Region, 2023-2030 (US$ Bn)
TABLE 12 Global Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 13 Global Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 14 Global Artificial Pancreas Device Systems Market, by Region, 2017-2022 (US$ Bn)
TABLE 15 Global Artificial Pancreas Device Systems Market, by Region, 2023-2030 (US$ Bn)
TABLE 16 North America Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 17 North America Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 18 North America Artificial Pancreas Device Systems Market, by Country, 2017-2022 (US$ Bn)
TABLE 19 North America Artificial Pancreas Device Systems Market, by Country, 2023-2030 (US$ Bn)
TABLE 20 United States Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 21 United States Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 22 Canada Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 23 Canada Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 24 Mexico Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 25 Mexico Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 26 Europe Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 27 Europe Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 28 Europe Artificial Pancreas Device Systems Market, by Country, 2017-2022 (US$ Bn)
TABLE 29 Europe Artificial Pancreas Device Systems Market, by Country, 2023-2030 (US$ Bn)
TABLE 30 Germany Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 31 Germany Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 32 France Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 33 France Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 34 United Kingdom Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 35 United Kingdom Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 36 Italy Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 37 Italy Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 38 Spain Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 39 Spain Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 40 Rest of Europe Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 41 Rest of Europe Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 42 Asia Pacific Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 43 Asia Pacific Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 44 China Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 45 China Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 46 Japan Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 47 Japan Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 48 India Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 49 India Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 50 South Korea Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 51 South Korea Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 52 South-East Asia Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 53 South-East Asia Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 54 Rest of Asia Pacific Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 55 Rest of Asia Pacific Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 56 Latin America Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 57 Latin America Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 58 Brazil Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 59 Brazil Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 60 Argentina Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 61 Argentina Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 62 Rest of Latin America Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 63 Rest of Latin America Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 64 Middle East and Africa Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 65 Middle East and Africa Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 66 GCC Countries Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 67 GCC Countries Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 68 South Africa Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 69 South Africa Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)
TABLE 70 Rest of Middle East and Africa Artificial Pancreas Device Systems Market, by Device Type, 2017-2022 (US$ Bn)
TABLE 71 Rest of Middle East and Africa Artificial Pancreas Device Systems Market, by Device Type, 2023-2030 (US$ Bn)